Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis Reply

被引：0
作者：
Singla, Shikha [1 ]
Putman, Michael [1 ]
Liew, Jean [3 ]
Gordon, Kenneth [2 ]
机构：
[1] Med Coll Wisconsin, Dept Rheumatol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA
[3] Boston Univ, Chobanian & Avedisian Sch Med, Dept Rheumatol, Boston, MA USA
来源：
LANCET RHEUMATOLOGY | 2023年 / 5卷 / 06期
关键词：
PSORIATIC-ARTHRITIS;
D O I：
10.1016/S2665-9913(23)00124-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E313 / E313
页数：1
相关论文
共 5 条
  • [1] Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
    Blauvelt, Andrew
    Papp, Kim A.
    Griffiths, Christopher E. M.
    Randazzo, Bruce
    Wasfi, Yasmine
    Shen, Yaung-Kaung
    Li, Shu
    Kimball, Alexa B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (03) : 405 - 417
  • [2] The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis A Prospective Cohort Study
    Eder, Lihi
    Haddad, Amir
    Rosen, Cheryl F.
    Lee, Ker-Ai
    Chandran, Vinod
    Cook, Richard
    Gladman, Dafna D.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (04) : 915 - 923
  • [3] Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network
    Ogdie, Alexis
    Alehashemi, Sara
    Love, Thorvardur Jon
    Jiang, Yihui
    Haynes, Kevin
    Hennessy, Sean
    Choi, Hyon
    Gelfand, Joel M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (09) : 918 - 922
  • [4] Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study
    Singla, Shikha
    Putman, Michael
    Liew, Jean
    Gordon, Kenneth
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (04) : 200 - 207
  • [5] Why Test for Proportional Hazards?
    Stensrud, Mats J.
    Hernan, Miguel A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1401 - 1402
1